Differential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cells

BACKGROUND: The importance of the genetic background of cancer cells for the individual susceptibility to cancer treatments is increasingly apparent. In melanoma, the existence of a BRAF mutation is a main predictor for successful BRAF-targeted therapy. However, despite initial successes with these...

Descripción completa

Detalles Bibliográficos
Autores principales: Arozarena, Imanol, Goicoechea, Ibai, Erice, Oihane, Ferguson, Jennnifer, Margison, Geoffrey P, Wellbrock, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079649/
https://www.ncbi.nlm.nih.gov/pubmed/24941944
http://dx.doi.org/10.1186/1476-4598-13-154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079649/
https://www.ncbi.nlm.nih.gov/pubmed/24941944
http://dx.doi.org/10.1186/1476-4598-13-154

Ejemplares similares